Plain Language Summary

Lyme disease is a tick-borne bacterial infection caused by Borrelia burgdorferi. Standard treatment is antibiotic therapy and is highly effective when initiated early. A significant subset of patients develop persistent symptoms after treatment (post-treatment Lyme disease syndrome). Integrative approaches for this group are increasingly researched but evidence remains preliminary.

What It Is

Lyme disease is the most common vector-borne disease in the United States and Europe. It is transmitted through the bite of infected black-legged ticks (Ixodes scapularis in North America). The causative bacterium, Borrelia burgdorferi, can affect multiple organ systems including the skin, joints, nervous system, and heart.

Integrative Approaches

Japanese Knotweed (Resveratrol/Emodin)
C

Preclinical

In vitro studies show emodin kills Borrelia burgdorferi including persister forms. No completed human RCTs.

Cat's Claw (Uncaria tomentosa)
C

Preclinical

In vitro antimicrobial activity against Borrelia. Used in integrative Lyme protocols. No human RCTs.

Garlic / Allicin
C

Preclinical

Allicin shows in vitro activity against Borrelia persister forms. No human clinical data.

Magnesium
B

Supportive

Commonly depleted in Lyme patients. Supplementation may support neurological symptoms and sleep quality. Not Lyme-specific evidence.

Omega-3 Fatty Acids
B

Supportive

Anti-inflammatory effects relevant to Lyme arthritis and neuroinflammation. Not Lyme-specific clinical trials.

Vitamin D
B

Observational

Deficiency common in Lyme patients. Supplementation to correct deficiency is reasonable. Not Lyme-specific outcome data.

Research Gaps

  • No human RCTs for herbal antimicrobials in Lyme disease.
  • Mechanism of post-treatment Lyme disease syndrome remains debated.
  • Biofilm-targeting strategies are promising but preclinical only.
  • Integrative protocol development needs rigorous clinical study design.

Citations

  1. Feng J et al. Identification of Essential Oils with Strong Activity against Stationary Phase Borrelia burgdorferi. Antibiotics. 2020.
  2. Wormser GP et al. The clinical assessment, treatment, and prevention of lyme disease. Clin Infect Dis. 2006.
  3. Lantos PM et al. Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA). Clin Infect Dis. 2021.

Disclaimer: Educational information only. Not medical advice. Lyme disease requires diagnosis and treatment by a qualified healthcare professional. Do not delay medical care.

Last updated: March 1, 2025